EX-23.1 5 exhibit231_q42022.htm EX-23.1 Document

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-268341) and Form S-8 (No. 333-236170, 333-254686 and 333-263648) of Black Diamond Therapeutics, Inc. of our report dated March 9, 2023 relating to the financial statements, which appears in this Form 10-K.



/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 9, 2023